MIR7973-1

Across TCGA pan-cancer cohorts, MIR7973-1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR7973-1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where MIR7973-1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR7973-1 is over-expressed in tumor.

HNSC, BRCA, and LUSC are the cancer types where MIR7973-1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR7973-1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+0.469	<.001	8	view →
BRCA	Female	II,III,IV	+0.085	.007	4	view →
LUSC	All	All	+0.286	.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR7973-1–HNSC

Open the HNSC breakdown →